Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
專家展望：10位分析師眼中的Sutro Biopharma
Sutro Biopharma (NASDAQ:STRO) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 7 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 7 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $12.5, a high estimate of $18.00, and a low estimate of $8.00. This current average has decreased by 11.79% from the previous average price target of $14.17.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination of how financial experts perceive Sutro Biopharma is derived from recent...
登入免費觀看全文
登入/註冊